Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 277-285

  Chatzizacharias, Nikolaos A ^a,b   Giaginis, Constantinos ^a   Gatzidou, Elisavet ^a   Tsourouflis, Gerasimos ^a   Sfiniadakis, Ioannis ^c   Alexandrou, Paraskevi ^a   Theocharis, Stamatios E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c ATHENS NAVAL HOSPITAL   (Greece)

Author keywords

Clinical significance; Endometrial adenocarcinoma; FAK; Immunohistochemistry; Src

Indexed keywords

FOCAL ADHESION KINASE; KI 67 ANTIGEN; PROTEIN TYROSINE KINASE;

ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 80051667973     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9310-6     Document Type: Article

References (34)

1. Guan JL, Shalloway D (1992) Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358:690-692
2. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT (1992) pp125FAK a structurally distinctive proteintyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:5192-5196
3. Hanks SK, Calalb MB, Harper MC, Patel SK (1992) Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89:8487-8491
4. Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons JT, Brugge JS (1992) Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp 125FAK in platelets. J Cell Biol 119:905-912
5. Zachary I, Sinnett-Smith J, Bombesin RE (1992) Vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3 T3 cells. Identification of a novel tyrosine kinase as a major substrate. J Biol Chem 267:19031-19034
6. Zachary I (1997) Focal adhesion kinase. Int J Biochem Cell Biol 29:929-934 (Pubitemid 27478877)
7. Schaller MD, Parsons JT (1994) Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 6:705-710 (Pubitemid 24295304)
8. Salasznyk RM, Klees RF, Williams WA, Boskey A, Plopper GE (2007) Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. Exp Cell Res 313:22-37 (Pubitemid 44958451)
9. Cary LA, Guan JL (1999) Focal adhesion kinase in integrinmediated signaling. Front Biosci 4:D102-113
10. Xing Z, Chen HC, Nowlen JK, Taylor SJ, Shalloway D, Guan JL (1994) Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol Biol Cell 5:413-421 (Pubitemid 24178320)
11. Rahimi N, Hung W, Tremblay E, Saulnier R, Elliott B (1998) c-Src kinase activity is required for hepatocyte growth factorinduced motility and anchorage-independent growth of mammary carcinoma cells. J Biol Chem 273:33714-33721 (Pubitemid 29005761)
12. Hauck CR, Hunter T, Schlaepfer DD (2001) The v-Src SH3 domain facilitates a cell adhesion-independent association with focal adhesion kinase. J Biol Chem 276:17653-17662
13. Frame MC (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602:114-130 (Pubitemid 34521791)
14. Hauck S D D, CR S D J (1999) Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71:435-478
15. Cox BD, Natarajan M, Stettner MR, Gladson CL (2006) New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99:35-52
16. MacPhee DJ, Mostachfi H, Han R, Lye SJ, Post M, Caniggia I (2001) Focal adhesion kinase is a key mediator of human trophoblast development. Lab Invest 81:1469-1483 (Pubitemid 33064274)
17. Furuta Y, Ilic D, Kanazawa S, Takeda N, Yamamoto T, Aizawa S (1995) Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene 11:1989-1995
18. Sorenson CM, Sheibani N (1999) Focal adhesion kinase, paxillin, and bcl-2: analysis of expression, phosphorylation, and association during morphogenesis. Dev Dyn 215:371-382 (Pubitemid 29377205)
19. Shen T-L, Park AY-J, Alcaraz A et al (2005) Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol 169:941-952 (Pubitemid 41002870)
20. Talamonti MS, Roh MS, Curley SA, Gallick GE (1993) Increase in activity and level of pp 60c-src in progressive stages of human colorectal cancer. J Clin Invest 91:53-60 (Pubitemid 23037252)
21. Lutz MP, Esser IB, Flossmann-Kast BB et al (1998) Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun 243:503-508 (Pubitemid 28414054)
22. Verbeek BS, Vroom TM, Adriaansen-Slot SS et al (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180:383-388 (Pubitemid 27014075)
23. Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE (2003) Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 134:221-226 (Pubitemid 37070342)
24. Myoui A, Nishimura R, Williams PJ et al (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028-5033 (Pubitemid 37022641)
25. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res 10:2307-2318 (Pubitemid 38445688)
26. Chatzizacharias NA, Kouraklis GP, Theocharis SE (2008) Clinical significance of FAK expression in human neoplasia. Histol Histopathol 23:629-650 (Pubitemid 351552349)
27. Laird AD, Cherrington JM (2003) Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents. Expert Opin Investig Drugs 12:51-64 (Pubitemid 36104643)
28. Chatzizacharias NA, Kouraklis GP, Theocharis SE (2007) Focal adhesion kinase: a promising target for anticancer therapy. Expert Opin Ther Targets 11:1315-1328 (Pubitemid 47604071)
29. Livasy CA, Moore D, Cance WG, Lininger RA (2004) Focal adhesion kinase overexpression in endometrial neoplasia. Appl Immunohistochem Mol Morphol 12:342-345 (Pubitemid 39602074)
30. Su JM, Gui L, Zhou YP, Zha XL (2002) Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. World J Gastroenterol 8:613-618 (Pubitemid 34918651)
31. Giaginis CT, Vgenopoulou S, Tsourouflis GS, Politi EN, Kouraklis GP, Theocharis SE (2009) Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma. Pathol Oncol Res 15:173-181
32. Chatzizacharias NA, Giaginis C, Diamanto Zizi-Serbetzoglou D et al (2010) Evaluation of the clinical significance of Focal Adhesion Kinase and Src expression in human pancreatic ductal adenocarcinoma. Pancreas 39:930-936
33. Macwhinnie N, Monaghan H (2004) The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma. Int J Gynecol Cancer 14:938-946 (Pubitemid 39238183)
34. Sobel G, Németh J, Kiss A, Lotz G, Szabó I, Udvarhelyi N, Schaff Z, Páska C (2006) Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynec Oncol 103:591-598 (Pubitemid 44740102)